Columbia Trust’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | $1.61M | Buy |
21,125
+4,380
| +26% | +$334K | 0.73% | 43 |
|
|
2023
Q3 | $1.16M | Buy |
16,745
+132
| +0.8% | +$9.15K | 0.67% | 48 |
|
|
2023
Q2 | $1.57M | Buy |
16,613
+845
| +5% | +$79.7K | 0.88% | 36 |
|
|
2023
Q1 | $1.3M | Buy |
15,768
+868
| +6% | +$71.8K | 0.75% | 40 |
|
|
2022
Q4 | $1.11M | Sell |
14,900
-2,722
| -15% | -$203K | 0.62% | 46 |
|
|
2022
Q3 | $1.46M | Sell |
17,622
-168
| -0.9% | -$13.9K | 0.82% | 32 |
|
|
2022
Q2 | $1.69M | Sell |
17,790
-32
| -0.2% | -$3.04K | 0.91% | 28 |
|
|
2022
Q1 | $2.14M | Buy |
17,822
+1,214
| +7% | +$146K | 1% | 25 |
|
|
2021
Q4 | $1.88M | Hold |
16,608
| – | – | 0.99% | 23 |
|
|
2021
Q3 | $1.88M | Buy |
16,608
+480
| +3% | +$54.3K | 0.99% | 23 |
|
|
2021
Q2 | $1.67M | Buy |
16,128
+1,111
| +7% | +$115K | 0.95% | 28 |
|
|
2021
Q1 | $1.26M | Buy |
15,017
+730
| +5% | +$61K | 0.78% | 35 |
|
|
2020
Q4 | $1.3M | Buy |
+14,287
| New | +$1.3M | 0.9% | 33 |
|
|
2020
Q2 | $973K | Buy |
14,099
+1,307
| +10% | +$90.2K | 0.87% | 38 |
|
|
2020
Q1 | $803K | Buy |
12,792
+141
| +1% | +$8.85K | 0.88% | 35 |
|
|
2019
Q4 | $983K | Buy |
+12,651
| New | +$983K | 0.88% | 37 |
|